Is the Second Revision of the International Staging System (R2-ISS) for Multiple Myeloma Valid in a Real-World Population from China?

被引：0
|
作者：
Yan, Wenqiang [1 ,2 ,3 ]
Li, Lingna [1 ,2 ]
Fan, Huishou [1 ,2 ]
Xu, Jingyu [1 ,2 ]
Deng, Shuhui [1 ,2 ]
Sui, Weiwei [1 ,2 ]
Xu, Yan [1 ,2 ]
Zou, Dehui [1 ,2 ]
Qiu, Lugui [1 ,2 ]
An, Gang [1 ,2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,Inst Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
[3] Inst Hematol & Blood, State Key Lab Expt Hematol, Tianjin, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-158751
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7255 / 7256
页数：2
相关论文
共 50 条
  • [1] Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
    Yan Wenqiang
    Fan Huishou
    Xu Jingyu
    Liu Jiahui
    Li Lingna
    Du Chenxing
    Deng Shuhui
    Sui Weiwei
    Xu Yan
    Zou Dehui
    Qiu Lugui
    An Gang
    [J]. 中华医学杂志(英文版), 2023, 136 (14)
  • [2] Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
    Yan, Wenqiang
    Fan, Huishou
    Xu, Jingyu
    Liu, Jiahui
    Li, Lingna
    Du, Chenxing
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Zou, Dehui
    Qiu, Lugui
    An, Gang
    [J]. CHINESE MEDICAL JOURNAL, 2023, 136 (14) : 1744 - 1746
  • [3] Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG)
    Kastritis, Efstathios
    Katodritou, Eirini
    Badelita, Sorina
    Bila, Jelena
    Seval, Guldane Cengiz
    Cvetkovic, Zorica
    Coriu, Daniel
    Spanoudakis, Emmanouil
    Dalampira, Dimitra
    Sretenovic, Aleksandra
    Sevastoudi, Aggeliki
    Bojan, Anca
    Mitrovic, Marko
    Danaila, Catalin
    Gavriatopoulou, Maria
    Roussou, Maria
    Charalampous, Charalampos
    Terpos, Evangelos
    Beksac, Meral
    Dimopoulos, Meletios A.
    [J]. LEUKEMIA & LYMPHOMA, 2024,
  • [4] Application of the Second Revision of the International Staging System(R2-ISS)in the prognostic assessment of newly diagnosed multiple myeloma
    严婕
    [J]. China Medical Abstracts(Internal Medicine), 2024, 41 (03) : 184 - 185
  • [5] The second revision of international staging system (R2-ISS) in newly diagnosed multiple myeloma patients: RWE settings
    Sretenovic, Aleksandra
    Mitrovic, Marko
    Vukosavljevic, Nikola
    Kecman, Natalija
    Jovanovic, Jelica
    Bukumiric, Zoran
    Bila, Jelena
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S93 - S93
  • [6] The second revision of the International Staging System (R2-ISS) stratifies progression-free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population
    Tan, Joanne L. C.
    Wellard, Cameron
    Moore, Elizabeth M.
    Mollee, Peter
    Rajagopal, Rajeev
    Quach, Hang
    Harrison, Simon James
    McDonald, Emma-Jane
    Ho, P. Joy
    Prince, H. Miles
    Augustson, Bradley M.
    Campbell, Philip
    McQuilten, Zoe K.
    Wood, Erica M.
    Spencer, Andrew
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (02) : E17 - E21
  • [7] Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
    D'Agostino, Mattia
    Cairns, David A.
    Lahuerta, Juan Jose
    Wester, Ruth
    Bertsch, Uta
    Waage, Anders
    Zamagni, Elena
    Mateos, Maria-Victoria
    Dall'Olio, Daniele
    van de Donk, Niels W. C. J.
    Jackson, Graham
    Rocchi, Serena
    Salwender, Hans
    Creixenti, Joan Blade
    van der Holt, Bronno
    Castellani, Gastone
    Bonello, Francesca
    Capra, Andrea
    Mai, Elias K.
    Durig, Jan
    Gay, Francesca
    Zweegman, Sonja
    Cavo, Michele
    Kaiser, Martin F.
    Goldschmidt, Hartmut
    Hernandez Rivas, Jesus Maria
    Larocca, Alessandra
    Cook, Gordon
    San-Miguel, Jesus F.
    Boccadoro, Mario
    Sonneveld, Pieter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (29) : 3406 - +
  • [8] Prognostic value of the second revision of the international staging system (R2-ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Kunisada, Kodai
    Yogo, Moe
    Oda, Yuki
    Sato, Kota
    Takei, Tomomi
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    [J]. HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
  • [9] Validation of second revision of international staging system (R2 ISS) in a real-world myeloma population: an Asia Pacific Myeloma and Related Diseases Registry (APAC MRDR) study
    Nagarajan, Chandramouli
    Kim, Kihyun
    Chen, Yunxin
    Tan, Melinda
    Gin, Gin Gan
    Huang, Jeffrey
    Tso, Allison Ching Yee
    Ooi, Melissa
    de Mel, Sanjay
    Moore, Elizabeth
    Chen, Fiona Pin-Yen
    Chng, Wee Joo
    Goh, Yeow Tee
    Spencer, Andrew
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S283 - S283
  • [10] Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice
    Mizuguchi, Makiko
    Okamoto, Yasunobu
    Yagi, Hikaru
    Kagawa, Kumiko
    Sekimoto, Etsuko
    Shibata, Hironobu
    Shigekiyo, Toshio
    Ozaki, Shuji
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (05) : 718 - 728
12345